ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,827.54
      -0.13%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Biora Therapeutics Inc (BIOR)

      7. Biora Therapeutics Inc (BIOR) News

      Biora Therapeutics Inc

      Biora Therapeutics Inc (BIOR)

      NASDAQ
      0.6677
      0.0127
      (1.94%)
      Closed July 26 4:00PM
      Delayed by 15 minutes
      0.6897
      0.022
      (3.29%)
      After Hours: 7:57PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      BIOR News

      Official News Only

      Form 8-K - Current report
      Edgar (US Regulatory)
      July 18 2024
      BIOR (1.94%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      June 14 2024
      BIOR (1.94%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      June 07 2024
      BIOR (1.94%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      June 06 2024
      BIOR (1.94%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      June 06 2024
      BIOR (1.94%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      June 06 2024
      BIOR (1.94%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      June 06 2024
      BIOR (1.94%)

      Form EFFECT - Notice of Effectiveness
      Edgar (US Regulatory)
      June 03 2024
      BIOR (1.94%)

      Form EFFECT - Notice of Effectiveness
      Edgar (US Regulatory)
      June 03 2024
      BIOR (1.94%)

      Form S-3 - Registration statement under Securities Act of 1933
      Edgar (US Regulatory)
      May 20 2024
      BIOR (1.94%)

      BIOR Discussion

      View Posts
      The Night Stalker The Night Stalker 2 months ago
      nice
      👍️0
      Arnold25764 Arnold25764 3 months ago
      Any possible catalyst here?
      👍️0
      Monksdream Monksdream 4 months ago
      BIOR new 52 lo
      👍️0
      Monksdream Monksdream 4 months ago
      BIOR new 52 lo
      👍️0
      Monksdream Monksdream 4 months ago
      BIOR 10Q due 3/26
      👍️0
      Monksdream Monksdream 4 months ago
      BIOR under $2
      👍️0
      glenn1919 glenn1919 5 months ago
      BIOR.................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 5 months ago
      BIOR..................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 8 months ago
      BIOR new 52 week low
      👍️0
      Monksdream Monksdream 8 months ago
      BOIR new 52 week low
      👍️0
      Monksdream Monksdream 8 months ago
      BIOR new 52 week low
      👍️0
      TheFinalCD TheFinalCD 8 months ago
      https://finviz.com/quote.ashx?t=BIOR&p=d

      https://dilutiontracker.com/app/search/BIOR
      👍️0
      Awl416 Awl416 8 months ago
      Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
      👍️0
      retireat40 retireat40 9 months ago
      Looked good this morning at 2.66 but a crappy close.
      👍️0
      Monksdream Monksdream 12 months ago
      BIOR Barchart Bottom 100
      Biora Therapeutics Inc NASDAQ: BIOR



      GoSymbol lookup
      Health Care : Biotechnology | Small Cap ValueCompany profile
      Biora Therapeutics, Inc. is a biotechnology company, which is focused on creating smart pills designed for targeted drug delivery to the gastrointestinal (GI) tract, and needle-free delivery of biotherapeutics. The Company's therapeutics pipeline includes two therapeutic delivery platforms: NAVICAP and BIOJET. NAVICAP is a targeted oral delivery platform of therapeutics to the site of disease in the GI tract, designed to improve outcomes for patients with inflammatory bowel disease (IBD). The NAVICAP drug delivery device is an investigational, clinical-stage, single-use ingestible device approximately the size of a fish oil capsule. BIOJET is a systemic oral delivery platform of biotherapeutics designed to replace injection with needle-free, oral delivery of molecules for better management of chronic diseases. The Company's targeted therapeutics pipeline programs include NAVICAP, BT-600 and BT-001. Its systemic therapeutics pipeline programs include BIOJET, BT-200 and BT-002.
      👍️0

      Your Recent History

      NASDAQ
      BIOR
      Biora Therapeutics
      Delayed Upgrade Clock